NCT04660214

Brief Summary

The main purpose of this trial is to evaluate two devices used in the treatment of Zenker Diverticulum using flexible endoscopy (LigaSure and SB-knife). Analyze the technical success, clinical success, relapses, complications, and the mean procedure time with each device prospectively in order to transfer objective and uniform results to routine clinical practice.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Jun 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Jun 2021Dec 2026

First Submitted

Initial submission to the registry

November 24, 2020

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 9, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

June 28, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

February 23, 2024

Status Verified

February 1, 2024

Enrollment Period

3 years

First QC Date

November 24, 2020

Last Update Submit

February 22, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Evaluate the technical success of endoscopic diverticulotomy with SB-Knife and LigaSure

    Technical success: achieving septotomy of the mucosa and transverse muscle fibers of the diverticulum septum.

    At the moment of the procedure

  • Evaluate clinical success of endoscopic diverticulotomy with SB-Knife and LigaSure

    Clinical success: disappearance of symptoms or their improvement one month after treatment, evaluated using the Eating-Assessment Tool-10 (\>=3 pathological) and Dakkak and Bennett scales (0: asymthomatic; 4 aphagia)

    One month after the procedure

Secondary Outcomes (3)

  • Analyze the mean procedure time with each of the two endoscopic techniques

    At the end of the recruitment

  • Analyze immediate and delayed complications with SB-Knife and LigaSure

    one month after the procedure

  • Determine the recurrence rates and the mean time to recurrence for each of the techniques

    at least three months after the procedure

Study Arms (2)

Vessel sealing device

ACTIVE COMPARATOR

Endoscopic diverticulectomy is performed with the LigaSure (TM) device

Device: septotomy

Dissecting Knife device

ACTIVE COMPARATOR

Endoscopic diverticulectomy is performed with the SB-Knife(TM) device

Device: septotomy

Interventions

septotomyDEVICE

endoscopic diverticulotomy

Dissecting Knife deviceVessel sealing device

Eligibility Criteria

Age18 Years - 110 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with endoscopically confirmed Zenker's diverticulum and presenting symptoms related to it.
  • Those who complete the symptom and quality of life questionnaires.
  • They must sign informed consent.

You may not qualify if:

  • Previous treatment of Zenker's Diverticulum
  • Those for whom Zenker's diverticulum is ruled out at endoscopy.
  • Chewing disorders and/or dysphagia secondary to neurological pathology and Oesophageal motility disorders
  • Those who do not want to participate in the study and/or who do not sign the informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mª Henar Núñez Rodriguez,

Valladolid, 47001, Spain

RECRUITING

MeSH Terms

Conditions

Zenker Diverticulum

Condition Hierarchy (Ancestors)

Diverticulum, EsophagealDiverticulumDiverticular DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Mª Henar Núñez-Rodriguez, MD PhD

    Gastroenterology Department, Hospital Rio Hortega

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mª Henar Nuñez-Rodriguez, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 24, 2020

First Posted

December 9, 2020

Study Start

June 28, 2021

Primary Completion

June 30, 2024

Study Completion (Estimated)

December 31, 2026

Last Updated

February 23, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations